KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Sales (2016 - 2025)

Historic Return on Sales for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to 0.37%.

  • Vertex Pharmaceuticals' Return on Sales rose 600.0% to 0.37% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.33%, marking a year-over-year increase of 3800.0%. This contributed to the annual value of 0.33% for FY2025, which is 3800.0% up from last year.
  • According to the latest figures from Q4 2025, Vertex Pharmaceuticals' Return on Sales is 0.37%, which was up 600.0% from 0.35% recorded in Q3 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Sales peaked at 0.43% during Q3 2021, and registered a low of 1.36% during Q2 2024.
  • For the 5-year period, Vertex Pharmaceuticals' Return on Sales averaged around 0.26%, with its median value being 0.37% (2022).
  • In the last 5 years, Vertex Pharmaceuticals' Return on Sales plummeted by -17300bps in 2024 and then surged by 17100bps in 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Sales (Quarter) stood at 0.37% in 2021, then fell by -4bps to 0.36% in 2022, then increased by 8bps to 0.38% in 2023, then dropped by -19bps to 0.31% in 2024, then increased by 19bps to 0.37% in 2025.
  • Its last three reported values are 0.37% in Q4 2025, 0.35% for Q3 2025, and 0.35% during Q2 2025.